Tixagevimab

(Synonyms: AZD8895; COV2-2196)
Revisión del cliente

Based on 1 Customer Validation

Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.05%
  • No. CAS: 2420564-02-7
  • Peso molecular:146.48 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00